Corrigendum to ‘Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study’

The authors regret that the name of the first author was entered incorrectly on the title page and running head of the article, as well as in the issue's Table of Contents. The name of the first author should be Justin B. Echouffo-Tcheugui, MD, PhD. The authors would like to apologise for any inconvenience caused. Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) StudyThe American Journal of MedicineVol. 135Issue 12PreviewIt remains unclear whether elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) can serve as a “risk equivalent” for cardiovascular disease to adults at high cardiovascular risk. Full-Text PDF